NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
CC E-008-2003-0-US-01 Scavenger Receptor B1 Targeting For The Treatment Of Infection, Sepsis And Inflammation US 60/422,105 Abandoned
NINDS E-291-1999-0-US-02 EFFICIENT GENERATION OF MIDBRAIN NEURONS FROM MOUSE EMBRYONIC STEM CELLS US ORD 10/258,975 Abandoned
NIAID E-285-2002-0-US-01 Lutzomyia Longipalpis polypeptides and methods of use US 60/422,303 Abandoned
NCI E-090-2000-1-US-06 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 US National Stage 10/182,506 7619057 Abandoned PDF
NICHD E-069-2000-3-US-05 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA,11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... US National Stage 10/281,794 7196074 Abandoned PDF
NCI E-157-2000-0-US-03 Immunogenicity Using a Combination of DNA and Vaccinia Virus Vector Vaccines US National Stage 10/258,570 7094408 Expired PDF
NCI E-336-2001-0-PCT-01 Amyloid B is a Ligand For FPR Class Receptors PCT PCT PCT/US02/34455 Expired
NCI E-289-2002-0-US-01 Methods to Prevent Tumor Recurrence by Blockade of TGF-Beta US 60/421,286 Abandoned
NCI E-342-2002-0-US-01 B-Defensins as activators of Dendritic Cells US 60/421,488 Abandoned
NIDDK E-171-2003-0-KR-01 Adenosine Derivatives As A3 Receptor Agonists KR ORD 10-2002-0065441 Abandoned
NIAID E-337-2001-0-IE-08 Immunconjugates Comprising CD4 and Immunogobulin Molecules for the Treatment of HIV Infection IE EP 02799169.4 Abandoned
NIAID E-337-2001-0-FR-05 Immunconjugates Comprising CD4 and Immunogobulin Molecules for the Treatment of HIV Infection FR EP 02799169.4 Abandoned
NIAID E-337-2001-0-DE-06 Immunconjugates Comprising CD4 and Immunogobulin Molecules for the Treatment of HIV Infection DE EP 02799169.4 Abandoned
NIAID E-337-2001-0-GB-07 Immunconjugates Comprising CD4 and Immunogobulin Molecules for the Treatment of HIV Infection GB EP 02799169.4 Abandoned
NIAID E-337-2001-0-EP-03 Immunconjugates Comprising CD4 and Immunogobulin Molecules for the Treatment of HIV Infection EP National Stage 02799169.4 Abandoned
NIAID E-337-2001-0-PCT-01 Immunconjugates Comprising CD4 and Immunogobulin Molecules for the Treatment of HIV Infection PCT PCT PCT/US02/34393 Expired
NIAID E-221-1997-0-US-06 CHIMERIC VACCINE AGAINST TICK-BORNE ENCEPHALITIS VIRUS US CON 10/279,130 6660273 Abandoned PDF
NIDDK E-064-2004-0-EP-14 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment EP DIV 10165256.8 Expired
NIDDK E-064-2004-0-PL-06 The Use Of Leptin For Treating Human Lipotrophy PL National Stage PL374301 Expired
NIDDK E-064-2004-0-CA-07 The Use Of Leptin For Treating Human Lipotrophy CA National Stage 2464277 Expired
NIDDK E-064-2004-0-CH-16 The Use Of Leptin For Treating Human Lipoatrophy CH EP 02793811.7 Expired
NIDDK E-064-2004-0-SE-24 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT SE EP 02793811.7 Expired
NIDDK E-064-2004-0-GB-21 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT GB EP 02793811.7 Expired
NIDDK E-064-2004-0-ES-19 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT ES EP 02793811.7 Expired
NIDDK E-064-2004-0-NL-23 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT NL EP 02793811.7 Expired
NIDDK E-064-2004-0-DK-18 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT DK EP 02793811.7 Expired
NIDDK E-064-2004-0-FR-20 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT FR EP 02793811.7 Expired
NIDDK E-064-2004-0-DE-17 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT DE EP 02793811.7 Expired
NIDDK E-064-2004-0-IT-22 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT IT EP 02793811.7 Expired
NIDDK E-064-2004-0-EP-08 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT EP National Stage 02793811.7 Expired
NHLBI E-329-2001-0-JP-04 Stem Cells That Transform to Beating Cardiomyocytes JP National Stage 2003-538339 Abandoned
NIDDK E-064-2004-0-AU-12 The Use Of Leptin For Treating Human Lipotrophy AU National Stage 2002359288 Expired
NHLBI E-329-2001-0-AU-03 Stem Cells That Transform to Beating Cardiomyocytes AU National Stage 2002337949 Abandoned
NIDDK E-064-2004-0-MX-05 The Use Of Leptin For Treating Human Lipotrophy MX National Stage PA/a/2004/003773 Expired
NHLBI E-329-2001-0-EP-06 Stem Cells That Transform to Beating Cardiomyocytes EP National Stage 02773854.1 Abandoned
NIDDK E-064-2004-0-PCT-02 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT PCT PCT PCT/US2002/033875 Expired
NIDDK E-064-2004-0-JP-04 The Use Of Leptin For Treating Human Lipoatrophy JP National Stage 2003-537565 Abandoned
NHLBI E-329-2001-0-PCT-02 Stem Cells That Transform to Beating Cardiomyocytes PCT PCT PCT/US02/33860 Expired
NCI E-256-2002-0-US-01 Method of Reducing the Activity of and Reducing the Concentration of a Mutant Kit Protein. US 60/420,143 Abandoned
NIDDK E-064-2004-0-US-03 The Use Of Leptin For Treating Human Lipotrophy US National Stage 10/279,129 Abandoned
NHLBI E-329-2001-0-CA-05 Stem Cells That Transform to Beating Cardiomyocytes CA National Stage 2464088 Abandoned
NCI E-307-2002-0-US-01 Sheathless CE-ESI-MS Interface US 60/420,003 Abandoned
NIA E-246-2002-0-US-01 MKp-1: A Screen for Anti-Inflammatory Drugs US 60/420,272 Abandoned
NCI E-030-2000-0-PCT-02 ABCA8 NUCLEIC ACIDS AND PROTEINS, AND USES THEREOF PCT PCT PCT/US02/33496 Expired
NCI E-292-2001-1-PCT-01 Use of Mx GTPases in The Prognosis And Treatment of Cancer PCT PCT COMB PCT/US02/33232 Expired
NIAAA E-101-2004-0-PCT-02 Use Of Inhibitors Of The Y2 Receptor Of Neuropeptide Y In The Treatment Of Alcoholism PCT PCT PCT/US02/01902 Expired
NIAAA E-101-2004-0-US-03 Use Of Inhibitors Of The Y2 Receptor Of Neuropeptide Y In The Treatment Of Alcoholism US National Stage 10/492,785 Abandoned
NHGRI E-020-2003-0-US-01 Molecular Abnormalities On Chromosome 1q In Hutchinson-Gilford Progeria Syndrome - HGPS US 60/419,541 Abandoned
NIMH E-348-2003-0-US-01 Methods And Formulations Comprising Agonists And Antagonists Of Nuclear Hormone Receptors US 60/419,454 Abandoned
NIAMS E-353-2001-2-PCT-01 Methods of Using Deacetylase Inhibitors as Tools To Promote Cell Differentiation And Regeneration PCT PCT COMB PCT/US2002/033570 Expired